Evidence of small study effects (Egger's test P<0.05) was found in all subgroups except for patients without cirrhosis, females, HBe-Ag negative patients, studies including patients with low HBV-DNA, studies including a high proportion of patients with elevated ALT, RCTs and studies performed in North America). This evidence concerns the gene GPT and Cirrhosis.